Stratos Wealth Partners, LTD. - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 35 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2021. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Stratos Wealth Partners, LTD. ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q2 2022$31,000
+40.9%
15,3430.0%0.00%
Q1 2022$22,000
-12.0%
15,343
-1.3%
0.00%
-100.0%
Q4 2021$25,000
-50.0%
15,5430.0%0.00%0.0%
Q3 2021$50,000
-35.1%
15,5430.0%0.00%
-50.0%
Q2 2021$77,000
-40.3%
15,543
-0.2%
0.00%
-50.0%
Q1 2021$129,00015,5790.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 181,169$259,0000.01%
CarsonAllaria Wealth Management, Ltd. 2,350$3,0000.00%
Engineers Gate Manager LP 15,428$22,0000.00%
Virtu Financial LLC 13,555$19,0000.00%
OSAIC HOLDINGS, INC. 1,602$3,0000.00%
FMR LLC 14$00.00%
US BANCORP \DE\ 2,000$3,0000.00%
WELLS FARGO & COMPANY/MN 1,682$2,0000.00%
NORTHERN TRUST CORP 42,000$60,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders